Alnylam Pharmaceuticals Inc (ALNY)
243.08
-3.92
(-1.59%)
USD |
NASDAQ |
Jun 28, 16:00
242.97
-0.11
(-0.05%)
After-Hours: 20:00
Alnylam Pharmaceuticals Net Income (Annual): -440.24M for Dec. 31, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -440.24M |
| December 31, 2022 | -1.131B |
| December 31, 2021 | -852.82M |
| December 31, 2020 | -858.28M |
| December 31, 2019 | -886.12M |
| December 31, 2018 | -761.50M |
| December 31, 2017 | -490.87M |
| December 31, 2016 | -410.11M |
| December 31, 2015 | -290.07M |
| December 31, 2014 | -360.40M |
| December 31, 2013 | -89.22M |
| Date | Value |
|---|---|
| December 31, 2012 | -106.01M |
| December 31, 2011 | -57.65M |
| December 31, 2010 | -43.52M |
| December 31, 2009 | -47.59M |
| December 31, 2008 | -26.25M |
| December 31, 2007 | -85.47M |
| December 31, 2006 | -34.61M |
| December 31, 2005 | -42.91M |
| December 31, 2004 | -32.65M |
| December 31, 2003 | -25.03M |
| December 31, 2002 | -4.136M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-1.131B
Minimum
2022
-440.24M
Maximum
2023
-833.72M
Average
-858.28M
Median
2020
Net Income (Annual) Benchmarks
| Pfizer Inc | 2.119B |
| BridgeBio Pharma Inc | -643.20M |
| Biomarin Pharmaceutical Inc | 167.64M |
| Alimera Sciences Inc | -20.13M |
| Arvinas Inc | -367.30M |